Compare · CRWD vs UTRS
CRWD vs UTRS
Side-by-side comparison of CrowdStrike Holdings Inc. (CRWD) and Minerva Surgical Inc. (UTRS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CRWD and UTRS operate in Computer Software: Prepackaged Software (Technology), so they compete in similar markets.
- CRWD is the larger of the two at $250.42B, about 2040.0x UTRS ($122.8M).
- CRWD has hit the wire 17 times in the past 4 weeks while UTRS has been quiet.
- CRWD has more recent analyst coverage (25 ratings vs 6 for UTRS).
- Company
- CrowdStrike Holdings Inc.
- Minerva Surgical Inc.
- Price
- -
- -
- Market cap
- $250.42B
- $122.8M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Computer Software: Prepackaged Software
- Computer Software: Prepackaged Software
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2019
- 2021
- News (4w)
- 17
- 0
- Recent ratings
- 25
- 6
CrowdStrike Holdings Inc.
CrowdStrike Holdings, Inc. provides cloud-delivered solutions for endpoint and cloud workload protection in the United States, Australia, Germany, India, Israel, Romania, and the United Kingdom. It offers 19 cloud modules on its Falcon platform through a software as a service subscription-based model that covers various security markets, such as corporate workload security, security and vulnerability management, managed security services, IT operations management, threat intelligence services, identity protection, and log management. The company primarily sells its platform and cloud modules through its direct sales team. CrowdStrike Holdings, Inc. was incorporated in 2011 and is headquartered in Sunnyvale, California.
Minerva Surgical Inc.
Minerva Surgical Inc., a commercial-stage medical technology company, focuses on developing, manufacturing, and commercializing minimally invasive solutions to meet the uterine healthcare needs of women. The company offers Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally invasive uterine tissue removal system to combine bladeless tissue resection and coagulation, continuous visualization, and intrauterine pressure monitoring; and Resectr Tissue Resection Device, a handheld surgical instrument to enable the hysteroscopic removal and diagnosis of endometrial polyps. Its devices are utilized by obstetrician-gynecologists across various medical treatment settings, including hospitals, ambulatory surgical centers, and physician offices. The company was incorporated in 2008 and is headquartered in Santa Clara, California.
Latest CRWD
- SEC Form 4 filed by CrowdStrike Holdings Inc.
- SEC Form 4 filed by CrowdStrike Holdings Inc.
- SEC Form 4 filed by CrowdStrike Holdings Inc.
- CrowdStrike Recommends Stockholders Reject the “Mini-Tender” Offer by Tutanota LLC
- SEC Form 4 filed by CrowdStrike Holdings Inc.
- CrowdStrike Named a Leader in the 2026 IDC MarketScape for Modern Endpoint Security for Enterprises
- SEC Form 4 filed by CrowdStrike Holdings Inc.
- CrowdStrike, AWS, and NVIDIA Expand Global Cybersecurity Startup Accelerator, Defining the Next Generation of Innovation for the Agentic Era
- Fal.Con Europe Sells Out at Record Pace as CrowdStrike Puts the AI Advantage in Defenders’ Hands
- SEC Form 4 filed by CrowdStrike Holdings Inc.
Latest UTRS
- SEC Form 15-12G filed by Minerva Surgical Inc.
- SEC Form 25 filed by Minerva Surgical Inc.
- SEC Form S-8 POS filed by Minerva Surgical Inc.
- 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- Why Lantheus Holdings Shares Are Trading Lower By Over 22%? Here Are Other Stocks Moving In Monday's Mid-Day Session
- 12 Health Care Stocks Moving In Monday's Intraday Session
- Minerva Surgical shares are trading lower after the company notified the Nasdaq of its intent to file a Form 25 with the SEC about voluntary delisting.
- Dow Gains Over 50 Points; Nippon Steel To Acquire U. S. Steel
- Why Arcutis Biotherapeutics Shares Are Trading Higher By Around 25%; Here Are 20 Stocks Moving Premarket
- 12 Health Care Stocks Moving In Monday's Pre-Market Session